Cargando…
A tumor targeting oncolytic adenovirus can improve therapeutic outcomes in chemotherapy resistant metastatic human breast carcinoma
Breast cancer is the most prevalent malignancy in women, which remains untreatable once metastatic. The treatment of advanced breast cancer is restricted due to chemotherapy resistance. We previously investigated anti-cancer potential of a tumor selective oncolytic adenovirus along with cisplatin in...
Autores principales: | Sakhawat, Ali, Ma, Ling, Muhammad, Tahir, Khan, Aamir Ali, Chen, Xuechai, Huang, Yinghui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6522519/ https://www.ncbi.nlm.nih.gov/pubmed/31097752 http://dx.doi.org/10.1038/s41598-019-43668-8 |
Ejemplares similares
-
Cisplatin Synergistically Enhances Antitumor Potency of Conditionally Replicating Adenovirus via p53 Dependent or Independent Pathways in Human Lung Carcinoma
por: Ali, Sakhawat, et al.
Publicado: (2019) -
Mesenchymal stem cell-mediated delivery of therapeutic adenoviral vectors to prostate cancer
por: Muhammad, Tahir, et al.
Publicado: (2019) -
Upregulation of Coxsackie Adenovirus Receptor Sensitizes Cisplatin-Resistant Lung Cancer Cells to CRAd-Induced Inhibition
por: Sakhawat, Ali, et al.
Publicado: (2017) -
428 Development of an Oncolytic Adenovirus to Treat Metastatic Colorectal Cancer
por: LaRocca, Christopher J., et al.
Publicado: (2023) -
Targeting Triple Negative Breast Cancer With Oncolytic Adenoviruses
por: Green-Tripp, Gabriela, et al.
Publicado: (2022)